Maurizio Sanguinetti to Antibodies, Monoclonal
This is a "connection" page, showing publications Maurizio Sanguinetti has written about Antibodies, Monoclonal.
Connection Strength
0.183
-
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? Expert Opin Biol Ther. 2018 04; 18(4):469-476.
Score: 0.183